Journal of Diabetes & Metabolic Disorders最新文献_第3页

ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations ACE I/D基因多态性与多囊卵巢综合征的表现

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-30 DOI: 10.1007/s40200-023-01335-w

Mojgan Asadi, Zeynab Nickhah Klashami, Nekoo Panahi, Yodit Oheb, Sara Khorasani, Mahsa M. Amoli

引用次数: 0

The association between heavy metal exposure and obesity: A systematic review and meta-analysis 重金属暴露与肥胖之间的关系:一项系统综述和荟萃分析

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-28 DOI: 10.1007/s40200-023-01307-0

Moein Zangiabadian, Amir Ghaffari Jolfayi, Seyed Aria Nejadghaderi, Ladan Amirkhosravi, Mojgan Sanjari

引用次数: 0

Risk prediction models for postpartum glucose intolerance in women with a history of gestational diabetes mellitus: a scoping review 有妊娠糖尿病史的妇女产后葡萄糖耐受不良的风险预测模型:一项范围综述

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-27 DOI: 10.1007/s40200-023-01330-1

Zhe Liu, Nan Jia, Qianghuizi Zhang, Weiwei Liu

引用次数: 0

Assessment of the relationship between self-efficacy criteria and rate of lower limb amputation in diabetic patients; a cross-sectional study 糖尿病患者自我效能标准与下肢截肢率的关系评价横断面研究

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-25 DOI: 10.1007/s40200-023-01331-0

Sajad Bagheri, Nader Salari, Ahmad Khoshay, Alireza Abdi

引用次数: 0

Association analysis between the VDR gene variants and type 2 diabetes VDR基因变异与2型糖尿病的相关性分析

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-25 DOI: 10.1007/s40200-023-01323-0

Shabnam Salehizadeh, Sara Ramezani, Mojgan Asadi, Mahdi Afshari, Seyed Hamid Jamaldini, Farhad Adhami Moghadam, Mandana Hasanzad

引用次数: 0

Elevated triglyceride/high-density lipoprotein-cholesterol ratio as a risk factor for progression to prediabetes: a 5-year retrospective cohort study in Japan 甘油三酯/高密度脂蛋白-胆固醇比值升高是进展为前驱糖尿病的危险因素:日本一项5年回顾性队列研究

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-25 DOI: 10.1007/s40200-023-01329-8

Masanori Shimodaira, Yu Minemura, Tomohiro Nakayama

引用次数: 0

Obesity as a risk factor in atrial fibrillation and heart failure 肥胖是心房颤动和心力衰竭的危险因素

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-25 DOI: 10.1007/s40200-023-01332-z

Jakub Jurica, Martin Jozef Péč, Jakub Benko, Tomáš Bolek, Peter Galajda, Marián Mokáň, Matej Samoš

{"title":"Obesity as a risk factor in atrial fibrillation and heart failure","authors":"Jakub Jurica, Martin Jozef Péč, Jakub Benko, Tomáš Bolek, Peter Galajda, Marián Mokáň, Matej Samoš","doi":"10.1007/s40200-023-01332-z","DOIUrl":"https://doi.org/10.1007/s40200-023-01332-z","url":null,"abstract":"Abstract Objectives The aim of this article is to provide an insight into the role of obesity as a risk factor, and as a potential etiologic agent of atrial fibrillation (AF) and heart failure (HF). Methods A narrative (non-systematic) review article summarizing currently available data regarding the interaction between obesity, AF and HF. Results Obesity is considered a risk factor of AF and chronic HF. Multiple recent studies indicate that obesity is also a potential causal factor in the development of AF and HF, the elucidation of pathological mechanisms of which could help devise new diagnostic and therapeutic modalities for these conditions. The discussion about obesity in relation to HF cannot omit the so-called obesity paradox, which represents a dilemma for clinicians, and it is still a source of irregularities regarding the strategy of weight reduction in obese patients with HF. Recently, the obesity paradox has also been assumed to play a role in the relationship between obesity and thromboembolic complications of AF. Conclusions Obesity is an independent and modifiable risk factor for AF and HF. In addition, there is an increasing volume of experimental and clinical data that suggests an important role of the epicardial adipose tissue in the pathophysiology of AF. However, several issues, such as the issue of optimal pharmacotherapy and weight reduction strategy in obese patients with HF remains still unanswered, and open for future investigation.","PeriodicalId":15604,"journal":{"name":"Journal of Diabetes & Metabolic Disorders","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135113590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparison of BMI and HbA1c changes before and during the COVID-19 pandemic in type 1 diabetes: a longitudinal population-based study 1型糖尿病患者在COVID-19大流行之前和期间BMI和HbA1c变化的比较:一项基于人群的纵向研究

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-25 DOI: 10.1007/s40200-023-01316-z

Marie Auzanneau, Dorothee M. Kieninger, Katharina Laubner, Christian Renner, Joaquina Mirza, Gerhard Däublin, Kirsten Praedicow, Holger Haberland, Claudia Steigleder-Schweiger, Bettina Gohlke, Angela Galler, Reinhard W. Holl

{"title":"Comparison of BMI and HbA1c changes before and during the COVID-19 pandemic in type 1 diabetes: a longitudinal population-based study","authors":"Marie Auzanneau, Dorothee M. Kieninger, Katharina Laubner, Christian Renner, Joaquina Mirza, Gerhard Däublin, Kirsten Praedicow, Holger Haberland, Claudia Steigleder-Schweiger, Bettina Gohlke, Angela Galler, Reinhard W. Holl","doi":"10.1007/s40200-023-01316-z","DOIUrl":"https://doi.org/10.1007/s40200-023-01316-z","url":null,"abstract":"Abstract Purpose To compare the changes in body weight and glycemic control before and during the COVID-19 pandemic in people with type 1 diabetes (T1D). Methods In 47,065 individuals with T1D from the German Diabetes Prospective Follow-up Registry (DPV), we compared the adjusted mean changes in BMI-Z-scores and HbA1c as well as the distribution of individual changes between four periods from March 2018 to February 2022, by sex and age group (4- < 11, 11- < 16, 16–50 years). Results At population level, the only significant pandemic effects were a slight increase in BMI Z-score in prepubertal children (girls: + 0.03 in the first COVID year vs. before, P < 0.01; boys: + 0.04, P < 0.01) as well as a stabilization of HbA1c in all subgroups or even improvement in women (− 0.08%, P < 0.01). At individual level, however, heterogeneity increased significantly (p < 0.01), especially in children. More prepubertal children gained weight (girls: 45% vs. 35% before COVID; boys: 39% vs. 33%). More pubertal girls lost weight (30% vs. 21%) and fewer gained weight (43% vs. 54%). More children had a decreasing HbA1c (prepubertal group: 29% vs. 22%; pubertal girls: 33% vs. 28%; pubertal boys: 32% vs. 25%) and fewer had increasing values. More women had stable HbA1c and fewer had increasing values (30% vs. 37%). In men, no significant changes were observed. Conclusion This real-world analysis shows no detrimental consequences of the two first COVID years on weight and HbA1c in T1D on average, but reveals, beyond the mean trends, a greater variability at the individual level.","PeriodicalId":15604,"journal":{"name":"Journal of Diabetes & Metabolic Disorders","volume":"62 5","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135111924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of clustering of non-communicable disease risk factors in a highly urbanized district of India: findings of a cross-sectional survey in Puducherry 印度高度城市化地区非传染性疾病风险因素聚集的流行程度:普杜切里横断面调查的结果

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-25 DOI: 10.1007/s40200-023-01318-x

Parthibane Sivanantham, Jaya Prakash Sahoo, Subitha Lakshminarayanan, Zachariah Bobby, Jeyanthi Anandraj, Sitanshu Sekhar Kar

引用次数: 0

Long-term effects of a telemedically-assisted lifestyle intervention on glycemic control in patients with type 2 diabetes – A two-armed randomised controlled trial in Germany 远程医疗辅助生活方式干预对2型糖尿病患者血糖控制的长期影响——德国的一项双臂随机对照试验

Journal of Diabetes & Metabolic Disorders Pub Date : 2023-10-25 DOI: 10.1007/s40200-023-01290-6

Annalena Dunkel, Katja von Storch, Martin Hochheim, Susanne Zank, M. Cristina Polidori, Christiane Woopen

{"title":"Long-term effects of a telemedically-assisted lifestyle intervention on glycemic control in patients with type 2 diabetes – A two-armed randomised controlled trial in Germany","authors":"Annalena Dunkel, Katja von Storch, Martin Hochheim, Susanne Zank, M. Cristina Polidori, Christiane Woopen","doi":"10.1007/s40200-023-01290-6","DOIUrl":"https://doi.org/10.1007/s40200-023-01290-6","url":null,"abstract":"Abstract Purpose Diabetes is considered one of the fastest growing diseases worldwide. Especially in the treatment of type 2 diabetes, lifestyle interventions have proven to be effective. However, long-term studies in real-world contexts are rare, which is why further research is needed. The aim of the present study is to investigate whether effects achieved in the context of a long-term lifestyle intervention can be sustained by patients in the long term. Methods In a two-arm randomized trial we compared diabetes care as usual to a lifestyle intervention combining telemedically support and individual needs-based telephone coaching. The study included 151 patients with type 2 diabetes randomized to either the intervention or control group. Intervention Group (IG; N = 86, 80.2% male, mean age: 59.7) received telemedical devices and telephone coaching over a period of 12 months, Control Group (CG; N = 65, 83.1% male, mean age: 58,8) received care as usual. The primary outcome was chance in Hb A1c . A follow-up survey was conducted after 24 months. Results The intervention group showed significantly better HbA1c- values compared to the control group at both 12 and 24 months (12 M: − 0.52 (-0.73; − 0.32), p < .000; 24 M: − 0.38 (-0.61; − 0.15), p = .001). The strongest change was seen in the first three months, with the best value obtained at 6 months and stable thereafter. Conclusion Combined telephone coaching with telemedicine support could lead to better long-term glycemic control in people with type 2 diabetes. In the future, more long-term studies should be conducted in real-world settings and lifestyle interventions should be offered more widely.","PeriodicalId":15604,"journal":{"name":"Journal of Diabetes & Metabolic Disorders","volume":"2 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134973192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0